{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:47:31Z","timestamp":1782431251455,"version":"3.54.5"},"reference-count":10,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1055\/s-0046-1823678","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:39:04Z","timestamp":1782430744000},"page":"001-003","source":"Crossref","is-referenced-by-count":0,"title":["Rituximab as a sustainable high-efficacy solution for multiple Sclerosis in Brazil"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-5437","authenticated-orcid":false,"given":"Cintia","family":"Ramari","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Faculdade de Medicina, S\u00e3o Lucas Hospital, Porto Alegre RS, Brazil."},{"name":"Hasselt University, Faculty of Rehabilitation Sciences, REVAL Rehabilitation Research Center, Hasselt, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-6115","authenticated-orcid":false,"given":"Giordani Rodrigues dos","family":"Passos","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Faculdade de Medicina, S\u00e3o Lucas Hospital, Porto Alegre RS, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-3620","authenticated-orcid":false,"given":"Jefferson","family":"Becker","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Faculdade de Medicina, S\u00e3o Lucas Hospital, Porto Alegre RS, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0045-1813263","article-title":"Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database","volume":"83","author":"A Damasceno","year":"2025","journal-title":"Arq Neuro-Psiquiatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1004795","DOI":"10.3389\/fimmu.2023.1004795","article-title":"Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic","volume":"14","author":"J de S\u00e8ze","year":"2023","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.lana.2025.101171","article-title":"Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs","volume":"49","author":"G D Silva","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"07","key":"ref4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1177\/13524585221098612","article-title":"Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary","volume":"28","author":"C C\u00e1rcamo","year":"2022","journal-title":"Mult Scler"},{"issue":"08","key":"ref5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaneurol.2023.1625","article-title":"Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis","volume":"80","author":"I Roos","year":"2023","journal-title":"JAMA Neurol"},{"issue":"08","key":"ref6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1474-4422(22)00209-5","article-title":"Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial","volume":"21","author":"A Svenningsson","year":"2022","journal-title":"Lancet Neurol"},{"issue":"06","key":"ref7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/ana.26914","article-title":"Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study","volume":"95","author":"P Alping","year":"2024","journal-title":"Ann Neurol"},{"issue":"04","key":"ref8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"K Hawker","year":"2009","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1380654","DOI":"10.3389\/fneur.2024.1380654","article-title":"Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients","volume":"15","author":"A Elgenidy","year":"2024","journal-title":"Front Neurol"},{"issue":"08","key":"ref10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1590\/0004-282X20180078","article-title":"Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis","volume":"76","author":"V D Marques","year":"2018","journal-title":"Arq Neuro-Psiquiatr"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1823678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:39:05Z","timestamp":1782430745000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1823678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":10,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["s00461823678"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1823678","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}